Department of Health and Human Services
National Institutes of Health
Translational Research for the Prevention and Control of Diabetes and Obesity (R18) Grant.
Purpose. Several large, controlled clinical trials (e.g. DPP, DCCT, and UKPDS) have established "gold standard" approaches for treating type 1 and type 2 diabetes, and for preventing or delaying type 2 diabetes in individuals at high risk for developing the disorder. Large controlled trials have also consistently demonstrated success in achieving weight loss though lifestyle approaches, although maintenance remains a challenge. Despite these advances, the efficacious interventions from these trials are rarely translated into widespread practice. Research is needed to test innovative adaptations of evidence based approaches to prevent and treat diabetes and obesity that can be disseminated and sustained in clinical health care practice and other settings beyond the research environment.
Key Dates:
Department of Health and Human Services
National Institutes of Health
Planning Grants for Translational Research for the Prevention and Control of Diabetes and Obesity (R34) Grant.
Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of Behavioral and Social Sciences Research (OBSSR) encourage NIH Clinical Trial Planning Grant Program grant (R34) applications from institutions/ organizations to develop and pilot test translational interventions for the prevention and control of diabetes and obesity that have a high potential to be adopted, and sustained in applied health care settings. Research must be based on widely accepted interventions previously demonstrated to be efficacious in clinical trials. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. The interventions proposed under this FOA should have the potential to be widely disseminated to clinical practice, individuals and communities at risk.
Key Dates:
The National Center for Complementary and Alternative Medicine (NCCAM)
The National Center for Complementary and Alternative Medicine (NCCAM) announces a new funding opportunity to enhance the development of clinical partnerships and translational research in the study of complementary and alternative medicine (CAM).
Key Dates:
Letters of Intent Receipt Dates:
Application Receipt Dates:
Earliest Anticipated Start Dates:
Expiration Date:
More Information about this program.
Download a PDF with more information
Translational Tools for Clinical Studies of CAM Interventions (R01)
The National Center for Complementary and Alternative Medicine (NCCAM) announces a new funding opportunity that encourages investigator(s)-initiated applications that propose to develop, enhance, and validate translational tools to facilitate rigorous study of complementary and alternative medicine (CAM) approaches that are in wide use by the public. This FOA focuses on encouraging the development of improved research methodology to study safety, efficacy, and clinical effectiveness of widely used CAM approaches, such as: mind-body interventions, manual therapies, yoga, and acupuncture.
Key Dates:
Application Due Date(s): July 17, 2009
Earliest Anticipated Start Date(s): April 1, 2010
Expiration Date: July 18, 2009
More Information about this program.
Download a PDF with more information
